Contract with Customer, Liability, Noncurrent of Aclaris Therapeutics, Inc. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary: Aclaris Therapeutics, Inc. quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
Aclaris Therapeutics, Inc. Contract with Customer, Liability, Noncurrent for the quarter ending 30 Sep 2025 was $17,492,000, a 17% decline year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Noncurrent, Quarterly (USD)

Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

Aclaris Therapeutics, Inc. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$17,492,000	-$3,690,000	-17%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$18,218,000			30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$19,206,000			31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$20,038,000			31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$21,182,000			30 Sep 2024	10-Q	06 Nov 2024	2024	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.